End-of-day quote
Other stock markets
|
||
- GBX | - |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | Tiziana Life Sciences Says US FDA Allows Enrollment of 20 More Patients in Foralumab MS Expanded Access Program | MT |
Chart calendar Tiziana Life Sciences PLC
Upcoming events on Tiziana Life Sciences PLC
No events available
Past events on Tiziana Life Sciences PLC
2022-09-27 12:00 pm | Preserving the Brain Conference |
2022-06-14 05:00 pm | BIO International Convention |
2022-06-09 04:45 pm | BioNJ Dinner Meeting |
2022-06-02 05:00 pm | Consortium of Multiple Sclerosis Centers Meeting |
2022-05-22 | FY 2021 Earnings Release |
2022-04-27 02:30 pm | B Riley Securities Virtual Neurology & Ophthalmology Conference |
2022-03-14 11:00 am | Investor Meeting - Key Opinion Leader |
2022-02-13 | Bio CEO & Investor Conference |
2022-01-27 04:00 pm | B. Riley Securities Virtual Oncology Conference |
2022-01-16 | Biotech Showcase Virtual Investor Conference |
2022-01-09 | Biotech Showcase |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-09-24 12:49 pm | Interim 2021 Earnings Release |
2021-09-08 04:15 pm | Business Update Call |
2021-08-18 03:30 pm | Q3 Virtual Investor Summit |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million GBP | Released Forecast Spread | -7,54 -7,50 -0.52% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million GBP | Released Forecast Spread | -7,55 -9,25 18.38% | -7,92 -6,41 -23.61% | -12,2 -9,32 -30.68% | -21,8 -26,7 18.54% | -11,7 -29,3 60.09% |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -7,56 -7,50 -0.8% | 0,00 0,00 - | -20,1 -12,5 -59.94% | -21,2 -26,8 20.75% | -12,3 -28,6 56.9% |
Net income Million GBP | Released Forecast Spread | -6,08 -6,30 3.48% | 0,00 0,00 - | -18,5 -11,0 -67.51% | -18,6 -26,8 30.38% | -12,3 -28,6 56.9% |
EPS GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -0,19 -0,12 -58.4% | -0,12 -0,30 60.31% |
Announcement Date | 04/04/19 | 17/06/20 | 17/05/21 | 23/05/22 | 26/04/23 |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 |
---|---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million GBP | Released Forecast Spread | -4,96 -2,70 -83.71% | -9,46 -5,43 -74.21% | -12,6 -8,53 -47.28% | -14,8 -14,2 -4.57% | ||
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -18,1 -8,63 -110.24% | -14,1 -14,2 0.62% | ||||
Net income Million GBP | Released Forecast Spread | -16,4 -7,13 -130.37% | -10,8 -14,2 23.51% | ||||
EPS GBP | Released Forecast Spread | -0,06 0,00 - | -0,06 -0,06 7.22% | -0,11 -0,06 -85.58% | |||
Announcement Date | 17/06/20 | 17/05/21 | 24/09/21 | 28/12/22 | 23/05/22 | 23/05/22 |
Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Tiziana Life Sciences PLC
- Stock Market
- Equities
- TLSA Stock
- Stock
- Calendar Tiziana Life Sciences PLC